LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Decision (EU) 2021/1886 of 27 October 2021 amending Implementing Decision (EU) 2019/570 as regards stockpiling rescEU capacities in the area of chemical, biological, radiological and nuclear incidents (notified under document C(2021) 7570) (Text with EEA relevance)

Commission Implementing Decision (EU) 2021/1886 of 27 October 2021 amending Implementing Decision (EU) 2019/570 as regards stockpiling rescEU capacities in the area of chemical, biological, radiological and nuclear incidents (notified under document C(2021) 7570) (Text with EEA relevance)

Implementing Decision (EU) 2021/1886 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Eligible costs of rescEU medical aerial evacuation capacities, emergency medical team type 3 capacities, medical stockpiling, CBRN decontamination and CBRN stockpiling capacities

Article 1

Open ↗

Implementing Decision (EU) 2019/570 is amended as follows: (1) in Article 2, paragraph 2 is amended as follows: (a) point (g) is replaced by the following: ‘(g) chemical, biological, radiological, and nuclear (CBRN) decontamination capacities;’ (b) the following point (h) is added: ‘(h) chemical, biological, radiological, and nuclear (CBRN) stockpiling capacities.’; (2) Article 3a is replaced by the following: ‘Article 3a Eligible costs of rescEU medical aerial evacuation capacities, emergency medical team type 3 capacities, medical stockpiling, CBRN decontamination and CBRN stockpiling capacities All cost categories referred to in Annex Ia to Decision No 1313/2013/EU shall be taken into account when calculating the total eligible cost of rescEU capacities.’; (3) Articles 3b, 3c and 3f are deleted; (4) in Article 3e, paragraphs 3 and 4 are replaced by the following: ‘3.   rescEU capacities referred to in points (c) to (h) of Article 2(2) shall be established with the objective of managing low probability risks with a high impact. 4.   Where rescEU capacities referred to in points (c) to (h) of Article 2(2) are deployed under the Union Mechanism, Union financial assistance shall cover 100 % of the operational costs, pursuant to Article 23(4b) of Decision No 1313/2013/EU.’; (5) the Annex is amended in accordance with the Annex to this Decision.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX In the Annex to Implementing Decision (EU) 2019/570, the following Section 8 is added: ‘8.    Stockpiling of chemical, biological, radiological and nuclear countermeasures and/or personal protective equipment aimed at assistance in the area of CBRN Tasks — Stockpiling of CBRN countermeasures, comprising though not limited to, personal protective equipment, devices, laboratory supplies and logistics elements, as well as complementing and supporting other rescEU capacities, such as the CBRN decontamination and detection, surveillance and monitoring capacities for the purpose of preparedness and response to a CBRN event, including in response to cross-border threats to health  ( 1 ) . Capacities — Materials and systems  ( 2 ) for decontaminating persons, infrastructure, buildings, vehicles, sensitive equipment and/or critical evidence, including from potential contamination with toxic industrial chemicals, recognised warfare agents, biological infectious agents (pathogens), biotoxins and radionuclides; — materials and devices necessary for detection, sampling, identification, surveillance and monitoring in order to keep safe an environment potentially exposed to CBRN agents; — materials and systems necessary for the containment of contamination and the management of waste and harmful by-products, including for contaminated water and clothes; — materials and systems necessary for fire containment and suppression in a CBRN event; — medical first line treatments, vaccines  ( 3 ) , relevant generic rapid diagnostic kits and antidotes against CBRN agents (e.g. atropine and iodine tablets); — support and disposable materials such as discharges and consumables that are complementary for CBRN response, tools needed for maintenance and stand-by (e.g. air bottle filler), containers for polluted or contaminated material of different agents; — CBRN related logistics support elements such as, but not limited to, tents, logistic containers, equipment for transporting victims, and decontamination tents at hospitals; — personal protective equipment  ( 4 ) and their regeneration or refill systems, if applicable, for individuals considered to be at risk  ( 5 ) both as front line workers and population; — laboratory supplies, including sampling material, laboratory reagents, equipment and consumables  ( 6 ) , to ensure laboratory capacity for CBRN-related risks; — body bags for CBRN contaminated fatalities; — any other items as needed, according to the identified risk. Main components — Appropriate storage facilities in the Union  ( 7 ) and adequate stockpiling monitoring system; — appropriate procedures ensuring the adequate packaging, transport and delivery of the products referred to under capacities, where needed; — appropriately trained personnel to oversee and handle the products referred to under capacities; — appropriate level of compliance with international standards and operation models, such as EU, WHO or NATO standards, including, where applicable, relevant Union legislation. Deployment — Availability for departure maximum 12 hours after the acceptance of the offer. ( 1 )   As defined in Decision No 1082/2013/EU. ( 2 )   Such as PPE regeneration and refill systems. ( 3 )   The quality requirements for vaccines should be those under point 6 above. ( 4 )   Covering the following categories: (i) eye protection; (ii) hand protection; (iii) respiratory protection; (iv) body protection; and (v) foot protection, in different sizes. ( 5 )   See footnote 2. ( 6 )   This may include, but is not limited to, RT-PCR reagents, such as enzymes, RNA extraction reagents, RNA extraction machine time, PCR machine time, primer and probe reagents, positive control reagents, PCR laboratory consumables (e.g. tubes and plates) and disinfectants. ( 7 )   For the purposes of the logistics of storage facilities, “in the Union” encompasses the territories of Member States and Participating States of the Union Civil Protection Mechanism.’

Other acts of the same type
Council Decision (CFSP) 2023/2287 of 23 October 2023 concerning restrictive measures in view of the situation in NigerCouncil Decision (CFSP) 2023/2296 of 23 October 2023 on Union support for activities of the Arms Trade Treaty Secretariat in support of the implementation of the Arms Trade TreatyCouncil Decision (EU) 2023/2417 of 23 October 2023 on the position to be taken on behalf of the European Union at the fifth meeting of the Conference of the Parties to the Minamata Convention on Mercury as regards the adoption of a decision to amend Annexes A and B to that ConventionCouncil Decision (EU) 2023/2426 of 23 October 2023 on the position to be taken on behalf of the European Union at the fifth meeting of the Conference of the Parties to the Minamata Convention on Mercury as regards the adoption of a decision establishing thresholds for mercury-contaminated waste in accordance with that ConventionCouncil Decision (EU) 2023/2427 of 23 October 2023 on the position to be taken on behalf of the European Union within the International Sugar Council as regards the extension of the International Sugar Agreement 1992Council Decision (EU) 2023/2428 of 23 October 2023 on the position to be taken on behalf of the European Union within the ACP-EU Committee of Ambassadors as regards the amendment of Decision No 3/2019 of the ACP-EU Committee of Ambassadors to adopt transitional measures pursuant to Article 95(4) of the ACP-EU Partnership AgreementCouncil Decision (EU) 2023/2446 of 23 October 2023 authorising the opening of negotiations with the People’s Republic of Bangladesh for a Partnership and Cooperation AgreementCouncil Implementing Decision (EU) 2023/2409 of 19 October 2023 extending temporary protection as introduced by Implementing Decision (EU) 2022/382Council Implementing Decision (EU) 2023/2410 of 19 October 2023 on the appointment of the Chair of the ECB Supervisory BoardCommission Implementing Decision (EU) 2023/2199 of 17 October 2023 granting derogations to certain Member States as regards the provision of statistics pursuant to Regulation (EC) No 1099/2008 of the European Parliament and of the Council on energy statistics (notified under document C(2023)6856)Council Decision (CFSP) 2023/2195 of 16 October 2023 amending Decision 2010/413/CFSP concerning restrictive measures against IranCouncil Decision (EU) 2023/2198 of 16 October 2023 on the signing, on behalf of the Union, of the Agreement in the form of an Exchange of Letters between the European Union and the Arab Republic of Egypt pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom’s withdrawal from the European Union

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next